Department Of Veterans Affairs
-
New therapeutic target for diabetes
The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes. Read MoreAug 20, 2015
-
Targeting bone metastasis
The rigidity of the bone extracellular matrix increases the ability of tumor cells to destroy bone, suggesting new targets for anticancer drug development. Read MoreJul 23, 2015
-
Study explores protein’s role in inflammation-associated cancer
An antioxidant protein may protect against colon cancer that develops in patients with inflammatory bowel disease, suggesting new strategies for reducing colon cancer risk in these patients. Read MoreJul 23, 2015
-
Hhex on cancer
A new mouse model demonstrates that the Hhex gene – which is linked to blood cancers – is critical for normal blood cell production. Read MoreJul 13, 2015
-
Delivering cells for heart repair
A polymer hydrogel material developed by Vanderbilt scientists improved the delivery of stem cells for heart repair. Read MoreJul 10, 2015
-
Boosting cell-based heart repair
A metabolic change in adult stem cells makes them less “fit” for regenerative heart therapies, suggesting that strategies to prevent this response may boost the therapeutic usefulness of the cells. Read MoreMay 15, 2015
-
Insights on lysosomal storage diseases
A novel mechanism could point to new therapies for a group of inherited diseases that share pathological features. Read MoreMay 14, 2015
-
Kids more likely to react to blood transfusions
Pediatric patients have a significantly higher incidence of transfusion reactions compared to adults, according to a study by Vanderbilt University researchers. Read MoreMay 4, 2015
-
Boosting beta cells in diabetes
New findings suggest that it might be possible to treat diabetes by regenerating insulin-producing beta cells in the pancreas. Read MoreApr 20, 2015
-
Surprising finding in the kidney
TGF-beta signaling in the kidney was thought to be a target for reducing renal fibrosis, but Vanderbilt researchers report that fibrosis still occurs in the absence of TGF-beta signaling. Read MoreApr 16, 2015
-
New player in heart cell growth
Vanderbilt researchers have identified a new protein involved in heart cell growth, which could improve understanding of pathologic cardiac hypertrophy. Read MoreApr 6, 2015
-
Target for atherosclerosis therapies
A newly identified “atheroprotective” gene is a tool for exploring plaque pathophysiology and may be a good target for therapies to slow atherosclerosis progression. Read MoreDec 17, 2014
-
Immune cell activity and melanoma
The activity of a certain factor in immune cells is essential for an anti-tumor response, emphasizing the need to consider the effects of anti-cancer therapies on immune cells. Read MoreNov 6, 2014
-
Skin cancer risks higher for soldiers serving abroad
Soldiers deployed to tropical and sunny climates are coming home with increased risk factors for a threat far from the battlefield: skin cancer. Read MoreSep 11, 2014
-
Factor impacts bone toughness
The factor ATF4 has a role in the toughness of bone and its resistance to fracture, suggesting new therapeutic targets. Read MoreJun 16, 2014
-
Potential mechanism for myeloma drug’s variable toxicity
A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication. Read MoreApr 30, 2014
-
Increased cell permeability may protect from colitis
Having a “leaky” gut may protect against colitis, a paradoxical finding that alters understanding of the role of cell permeability in intestinal homeostasis and immune regulation. Read MoreApr 25, 2014
-
Delirium increases long-term disability
Patients who suffer a longer duration of delirium in the intensive care unit are more likely to experience long-term disability after discharge. Read MoreMar 17, 2014
-
Probing the pathogenesis of leukemia
A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia. Read MoreFeb 27, 2014
-
New direction for treating lung cancer
Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer. Read MoreFeb 7, 2014